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Abstract 
Health has no counter-value. It is not traded and the health market does not exist as a classic form of market in other 
industries. From the economists’ perspective health can be considered as the basic raw material produced by consumers, 
and therefore each level of the health stock of an individual and its level of decrease is a consequence of numerous factors 
beyond the control of the individual itself. 
Due to the great importance of blood and blood components being drugs of human origin, European Union legislation in 
the field of transfusion aims to provide so called "safe blood", whose collection is done on the principles of voluntariness, 
anonymity and for free of charge. 
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1. Introduction 
It is hard to imagine modern business, nowadays, without the marketing planning, which is the cornerstone 
to the future design and analysis of performed business activities and procedures. Marketing planning is a part 
of the management process that controls the future situation of an organization, so as to determine primary 
goals and the most efficient means to achieve them. 
On the first sight, perhaps largely unknown, unattractive and completely insignificant discipline, marketing 
planning of blood and blood products consumption upon which, practically, all surgical intensive procedures 
lie. 
Most of the works of health economists in the field of marketing is focused on goods such as drugs, 
alcohol, tobacco, etc. Rare are the examples dealing with health or pharmaceutical marketing. Up to now, 
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economic experts, consciously or not, left health sector and all flows within it to health care workers – 
medicine workers, dentists and pharmacists. Since the beginning of the eighties, however, the trend changed 
by economists entering into the health sector, which is in line with the macroeconomic picture and Bosnia and 
Herzegovina’s devotion to join the European Union. 
2. Blood management development 
In medical practice, blood is used as a pharmaceutical tool, all because of its achievements in fields of its 
collecting, processing, storage and distribution. The fact that the most common risk in blood transfusion 
comes from an error in the blood delivery, supports the claim that blood is considered very important 
pharmaceutical agent.  
For centuries, battlefields were the place where the surgeons faced the loss of blood and on the very 
battlefield bleeding was identified as the cause of death. After the attack on the World Trade Center in New 
York, September 11th 2001, medical doctors of the United States of America Army joined the Society for the 
Advancement of Blood Management, and the interest for this type of management increased. High prices of 
blood transfusion in the war times and logistics difficulties, demanded new approaches to blood storing. 
The main reason for defining the process of ensuring sufficient amounts of blood is reflected in the need to 
provide sufficient quantities of high quality and safe blood, as well as to set standards of health care, in the 
field of transfusion, that meet the highest European standards, in the process of collecting, testing, processing, 
storage, distribution and release of human blood and blood components. 
Bosnia and Herzegovina's commitment are European integrations, and the goal of present European Union 
legislation in the field of transfusion is to provide blood and blood components as a remedy of human origin 
based on the principles of voluntary, anonymous and free donating  from the own sources. This implies a 
good organization of transfusion services and quality control as one of the conditions for safe and quality 
transfusion treatment which is available to every patient. 
High level of human blood usage in therapeutic purposes implies respect of certain principles formalized in 
the form of an EU directive by the expert bodies and the European Union Commissions for Transfusion 
Medicine. This directive dating from 2002. and later adopted amendments, establishes quality and security 
standards regarding the collection, testing, processing, storing and distributing blood and blood components. 
It is applied in the European Union countries and other countries that are in the process of accession to the 
European Union. In this regard, and in order to prepare for international integration project was launched 
under the name "Safe blood" so as involve Balkans countries in the process of standardization and adjustment 
to European norms in this field. 
3. Health marketing 
Health Marketing Development opened health institutions for breakthrough of concepts and methods from 
other industries and has helped the development of modern business practices in the area of health. Request 
for marketing skills is certainly growing. Profitability of health personnel who understand marketing can be 
very significant. Health institutions at the present, and especially in the future, will certainly value such skills. 
The focus of economists for health care can be, inter alia, explained by the fact that health has no counter-
value. From the economists’ perspective health can be considered as the basic raw material produced by 
consumers, and therefore each level of the health stock of an individual and its level of decrease of 
consequence of numerous factors beyond the control of the individual itself. 
Considering health as "raw material", some governments have passed a series of laws, regulations and 
recommendations regarding the use of health services. 
Rights defined in the Convention on human rights in Nice 2001, are to be applied as well to the patients‘ 
rights in countries whose national  laws do not care about the protection.  
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4. Health market in Republika Srpska 
 
Blood management program as a result has providing of integrated patients care program, which will 
reduce the costs of their stay in hospitals and help removing transfusion contraindications, and thus increase 
the satisfaction of patients and providers of health services. Thorough and continuous education of medical 
doctors in the blood management program is of a special importance. Namely, an excellent set of equipment 
does not make a good blood management, but primarily a set of good medical doctors willing to exchange 
information on the currently available techniques of blood management, and to compare them with own 
knowledge and skills. 
Due to the great importance of blood and blood components, as well as of drugs of human origin, 
Republika Srpska adopted the Law on transfusion medicine in 2008 ("Official Gazette of Republika Srpksa" 
No 1/08), as well as a series of by-laws regulating this matter. Also, Republika Srpska Government adopted 
the Strategy of safe blood in Republika Srpska for the period until 2015, which means a great step forward in 
providing sufficient amounts of safe blood. At the same time, the adoption of the Strategy means moving 
closer to resolving this important branch of medicine in the way in which it was done in the European Union, 
as membership in the EU implies a commitment to the area of transfusion medicine be arranged in the way it 
was done in the member countries of the European Union. 
Activities of transfusion medicine in Republika Srpska are performed by the Institute for transfusions of 
Republika Srpska, as a reference and an independent medical institution headquartered in Banja Luka, 
medical centers for transfusions and hospital services. Annually, approximately 24 thousand units of blood are 
collected, which is less than 18 donations per 1000 citizens. Approximately 30% blood out of this is collected 
through voluntary blood donation, and the remaining 70% of designated (family) blood donors. This is 
unfavorable; it impedes functioning and does not allow the existence of permanent blood reserves. According 
to the recommendations of the World Health Organization and the Council of Europe, all or at least the 
biggest part of blood should be collected from voluntary blood donors, since the statistics showed that this 
blood is safer and in much smaller percentage of reactivity to the results of testing to the transmission 
diseases. According to the provisions of the Law, the minimum normative reserve is to collect blood from at 
least 3% of the population. Hospital transfusion services are the only authorized hospital blood banks, which 
issue blood for transfusion treatment of patients. All units of collected blood should necessarily be tested 
according to the Program of blood testing in Republika Srpksa, which is based on international standards. 
In order to provide sufficient amounts of blood and blood components of high quality and safety, with 
maximum efficiency and minimum risk for the donors and the patient, the transfusion service must have a 
quality management system. According to European Council Directive No. 2002/98/EC the establishment of 
competent regulatory body which regularly control quality system and issues licenses for transfusion services 
is required. Quality management system in transfusion is based on the principles of Good manufacturing 
practice for drugs in medicine (European Council Directive 91/356/EC and ISO 9001-2000 standards). Safe 
blood and quality standards require monitoring and evaluation of all procedures in practice, quality equipment 
and reagents, preservation of so called "Cold chain" in the transport, storage and distribution of blood, and 
well educated and trained staff.  
5. Specifying marketing goals and formulating marketing strategy 
Aims of promoting blood donating in 2010 are: 
 increase collecting of the full blood doses for 15% in comparison to the last year; 
 increase the percentage of processing full blood doses at 60%;  
 reach level of 60% of fulfilling the requirements for blood and blood products doses; 
 educational and motivational activities to raise awareness and knowledge about the voluntary, anonymous 
and free blood donating. 
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Program for the motivation and involvement of the new voluntary blood donors and retention of regular 
voluntary blood donors, should apply a multidisciplinary approach to the voluntary blood donation by 
including a wider social community in these activities. 
The main activities of marketing strategy are: 
 informing and educating the whole population; 
 education of volunteer organizers of voluntary blood donors and voluntary blood donors’ associations; 
 long-term national programs to raise awareness and promote voluntary blood donations etc. 
These are conducted by organizing seminars, lectures, preparation and distribution of promotional 
materials, media promotion of voluntary blood donations (videos, interviews, posters, billboards with 
messages for the target population groups that are presented accordingly to the planned dynamics), giving 
recognitions for a certain number of blood donations, gathering voluntary blood donors, and media promotion 
of blood donations. 
For the implementation of marketing strategy the main actors should be the Institute for transfusions of 
Republika Srpska, the Red Cross and other non-governmental organizations, and in cooperation with 
institutions, companies and means of media communication. 
6. Conclusion 
Considering the current situation and working conditions, it can be said that the present system of 
transfusion services in Republika Srpska is inadequate, unreasonable and unprofitable.  
It is necessary to access the reorganization of transfusion service, to modernize it, to raise the work quality, 
to have specialized personnel in all work areas, to introduce a quality system and control, to rationalize the 
use of blood and blood components. 
Continuous and large campaign to promote blood donating only from voluntary blood donors is needed. In 
this manner, an adequate amount of safe blood and blood components from own sources for transfusion 
treatment of patients would be provided. 
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